Vincent, Jean-Louis, O'Brien, James, Wheeler, Arthur, Wittebole, Xavier, Garg, Rekha, Trzaskoma, Benjamin L, ...
Abstract Introduction Several studies have indicated that early identification and treatment of patients with severe sepsis using standard supportive care improves outcomes. Earlier treatment with...
Laterre, Pierre-François, Wittebole, Xavier
Abstract Administration of drotrecogin alfa (activated) has been demonstrated to reduce mortality in patients with severe sepsis who are at high risk for death or who have multiple organ dysfunction....
Laterre, Pierre-François, Wittebole, Xavier
Administration of drotrecogin alfa (activated) has been demonstrated to reduce mortality in patients with severe sepsis who are at high risk for death or who have multiple organ dysfunction. This...
Vincent, Jean-Louis, O'Brien, James, Wheeler, Arthur, Wittebole, Xavier, Garg, Rekha, Trzaskoma, Benjamin L, ...
Laterre, Pierre-François, Wittebole, Xavier
Administration of drotrecogin alfa (activated) has been demonstrated to reduce mortality in patients with severe sepsis who are at high risk for death or who have multiple organ dysfunction. This...